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ABSTRACT 
 
Introduction: 
Tuberculosis and HIV are major public health problems in Botswana. The Botswana 
National Tuberculosis Control Programme (BNTP) was established in 1975. Short 
course chemotherapy was introduced in 1986 and the Directly Observed Treatment 
(DOT) Strategy was adopted in 1993. In the face of growing TB notification rates, a 
low country average cure rate, human resource constraints in health facilities and 
sometimes poor accessibility to health facilities by weak patients and those living far 
away, Botswana decided to offer home-based care using volunteers or family 
members. 
 
Setting:  
Kweneng West Subdistrict, a rural area in Botswana 
 
Aim and objectives:  
The aim of this study was to assess the success of home-based DOT in the 
management of tuberculosis compared to facility-based DOT in Kweneng West 
Subdistrict, Botswana and to explore the acceptability of home-based DOT among TB 
patients, TB treatment supervisors and health workers. Objectives: 
- To compare treatment outcomes for patients receiving home-based DOT and 
those receiving facility-based DOT through the following criteria: 
- To compare patient contact(s) tracing efforts among home-based providers and 
facility-based providers 
- To establish TB patient’s, TB treatment supervisor’s and health worker’s 
perceptions about home-based DOT 
 
Methods: 
A quantitative, observational study combined with qualitative in-depth interviews. 
Participants were selected from TB patients who attended treatment from January 
2006 till June 2008 at all main clinics of Kweneng West Subdistrict, Botswana. The 
interview purposively selected health care workers, TB patients and community 
supervisors to establish their thoughts about HB DOT. A framework approach was 
used to analyse interviews. 
 
Results: 
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Treatment outcomes and, particularly, the cure rates were not statistically different 
between FB DOT, HB DOT and MX DOT. However there was a surprisingly 
difference in contact tracing, with FB DOT performing better than other DOT types. 
Interviews revealed that patients were happy with their choice of DOT types. Among 
reasons to choose HB DOT was the need to shorten distances for DOT. Among 
reasons to choose FB DOT were the needs to ensure safety through supervision by 
nurses as opposed to lay people (community supervisors) and to obtain injections that 
no community supervisor is allowed to administer. A mix of HB DOT and FB DOT 
was generally adopted to allow flexibility in the administration of DOT for few 
patients. Overall cure rate was 78.5% and successful treatment rate was 83%. 
 
Conclusion: 
The introduction of HB DOT and the option given to choose this DOT type is 
supported. Indeed allowing patient’s preference of DOT type may impact positively 
on patients’ satisfaction and adherence to medication. On the other hand, issues were 
still raised by all stakeholders to help improve the flexibility and sustainability of HB 
DOT. Further studies may be needed to understand the better performance of FB DOT 
in contact tracing. 
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I- INTRODUCTION, BACKGROUND AND MOTIVATION 
 
Although seen as a global emergency since 1993, tuberculosis (TB) still resulted in 9 
million new cases and 2 million deaths in 2004, of which 95% and 98% respectively 
happened in developing countries. (1, 2) The economically active 15-50 year old age 
group is the worst affected. (2, 3) 
 
Presently Botswana has one of the highest notification rates in the world despite a 
previous decline in rates between 1975 and 1989. (2, 3) The 1990s have seen a 
constant rise in notification rates, blamed mainly on the HIV (human 
immunodeficiency virus) scourge. (2, 3) Notification rates show more than 509 cases 
per 100000 people annually since 2000. (2) Multidrug resistant (MDR)-TB cases are 
also on the rise. (2, 3) 
 
The Botswana National Tuberculosis Control Programme (BNTP) was established in 
1975. (2) Short course chemotherapy was introduced in 1986 and the Directly 
Observed Treatment (DOT) Strategy was adopted in 1993. (2) Supervision of the 
entire treatment course is offered. (3) 
 
In the face of growing TB notification rates, a low country average cure rate, human 
resource constraints in health facilities and sometimes poor accessibility to health 
facilities by weak patients and those living far away, Botswana decided to offer home-
based care using volunteers or family members. (3) 
 
Many studies conducted in different countries support the usefulness of a community-
based TB programme. (3) In Botswana only a pilot study assessed the cost-
effectiveness of this programme. 
 
This study, therefore, focuses on determining the actual effectiveness of home-based 
DOT in Botswana, in order to contribute to the debate concerning how to strengthen 
the DOT approach.    
 
II- OVERVIEW OF LITERATURE 
A- Aetiology, mode of transmission and epidemiology of tuberculosis   
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Tuberculosis is one of the oldest diseases affecting humans. (1) Its causal agents 
belong to the Mycobacterium tuberculosis complex. (1, 2) Mycobacterium 
tuberculosis remains the most frequent and important agent to cause human disease. 
(1) However the complex also includes Mycobacterium bovis, Mycobacterium 
africanum and Mycobacterium microti. (1, 2)  
 
Other Mycobacterial species that are gaining importance with the advent of 
HIV/AIDS (human immunodepression virus/acquired immunodepression syndrome) 
are labelled as Mycobacterium Other Than Tuberculosis (MOTT) infections. (1, 2) 
 
Tuberculosis (TB) primarily spreads through droplets expelled by an infectious 
patient who coughs and/or sneezes. (2) Infectious individuals are those with acid and 
alcohol fast bacilli (AAFB) smear positive sputum. (1, 2)  
 
After infection (contact) the host immune system response usually restrains the 
Mycobacterium and therefore prevents the occurrence of the disease. (1, 2) 
Asymptomatic dormant or latent bacilli may remain in the host body. (1) Latent 
bacilli may be reactivated later on and produce a disease in individuals with a poor 
immune system response. (1) 
 
Disease is usually pulmonary but may affect any organ or may be disseminated. (1) 
Pulmonary tuberculosis with AAFB in the sputum is the sole infectious form. (2) 
 
As HIV depresses the immune system response, it fuels the development of the 
disease “tuberculosis”. (1, 2) Other factors that influence progression from infection 
to disease are: malnutrition, alcohol, diabetes mellitus, silicosis, smoking and some 
malignancies. (2) However HIV infection remains the most powerful factor and it 
triples, to 30-50%, the lifetime risk of acquiring TB. (2, 3, 4) 
 
Despite the impact of HIV infection on the course of the TB epidemic, TB can 
eventually be controlled because:  
- Human beings are the sole reservoir of Mycobacterium tuberculosis. They are 
the source of infections and patients can easily be identified. (2) 
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- Proper treatment can limit transmission. (2) 
- Response to TB therapy in HIV positive individuals is similar to the response in 
HIV negative individuals. (4) 
 
Meanwhile figure 1 shows that the trends of notification in Botswana are still 
worrisome, like in many countries with high HIV prevalence. (2, 4) 
 
In Botswana, 60-86% of TB patients are co-infected by HIV. Young adults who are 
mostly affected by HIV are therefore also carrying the burden of TB over the past 10-
20 years. 
 
Figure 1: Trends of notification (3) 
 
 
 
 
 
 
 
 
 
 
 
 
 B- Directly Observed Treatment Strategy “DOTS”. 
 
Different broad strategies are needed to control TB. (4)  Presently three mechanisms 
summarize these options (4): 
- reducing transmission of TB 
- reducing reactivation of latent TB infection 
- reducing HIV transmission    
 
Detecting infectious TB individuals is at the centre of controlling transmission. (4) 
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TB NOTIFICATION RATE PER 100,000 POPULATION-1975-2002.
0
100
200
300
400
500
600
700
1
9
7
5
1
9
7
6
1
9
7
7
1
9
7
8
1
9
7
9
1
9
8
0
1
9
8
1
1
9
8
2
1
9
8
3
1
9
8
4
1
9
8
5
1
9
8
6
1
9
8
7
1
9
8
8
1
9
8
9
1
9
9
0
1
9
9
1
1
9
9
2
1
9
9
3
1
9
9
4
1
9
9
5
1
9
9
6
1
9
9
7
1
9
9
8
1
9
9
9
2
0
0
0
2
0
0
1
2
0
0
2
Reporting year
R
a
te
 /
 1
0
0
.0
0
0
Rate Trend
 8 
DOTS strategy emphasises the need to find infectious cases and to ensure that they 
are cured from TB. (4) DOTS strategy finds its rationale in decreasing the possibility 
of relapses as it offers high standard care. (25)  The World Health Organisation 
(WHO) recommends the DOTS strategy to National TB Programmes of all countries. 
(4, 6) 
 
The whole DOTS strategy comprises the following elements (2):  
- Political commitment with increased and sustained financing: Treatment of TB 
is provided free of change to all patients in Botswana and the government of 
Botswana participates actively in national and international activities related to 
TB.   
- Case detection through quality assured bacteriology: Many laboratory facilities 
are scattered around Botswana.  Two referral laboratories perform 
Mycobacterium cultures. Case detection may be hampered by the health 
seeking behaviour of people. (22)  Indeed many patients will delay to seek 
medical attention. (22,23) However trends show better knowledge of TB and its 
cause, but more efforts need to be made in terms of community education and 
cooperation between modern and traditional medicines. (22,23)  
- Standardized treatment with supervision and patient support (directly observed 
treatment: DOT): Botswana uses a 6-month course for new patients. 
Supervision is provided throughout the entire course of treatment. (see Table 2 
for treatment regimens) Other countries such as Zambia and Tanzania use 
Rifampicin only during initial phase (2 first months) and have therefore a 8-
month course. (9)(10)(11)(14)     
- Uninterrupted supply of quality-assured drugs 
- Monitoring and evaluation system and impact measurement: The Botswana 
National Tuberculosis Programme (BNTP) has established clear recording and 
monitoring tools. Health facilities use paper-based recording registers and 
districts levels use both paper-based and electronic TB registers for easy data 
analysis. 
-  
- DOTS-Plus strategy was instead introduced in 1998 to include requirements 
related to the management of MDR-TB. (26) MDR-TB, and even extensively 
drug resistance TB (XDR-TB), are a growing health problem in Botswana. (2) 
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Kweneng East sub-district that is next to Kweneng West sub-district (study 
location) is leading in Botswana in terms of number of MDR-TB cases. (27) 
 
Treatment is provided according to a specific categorisation adopted by BNTP. 
Following recommendations by the WHO, Botswana defines TB cases as follows (2): 
 New: A patient who has never had treatment for TB or who had previously 
taken anti-tuberculosis treatment for less than 1 month 
 Relapse: A patient previously treated for TB who has been declared cured or 
treatment completed, and is diagnosed with sputum smear-positive or culture-
positive TB 
 Treatment after failure: A patient who is started on a re-treatment regimen 
after having failed previous treatment, i.e., sputum positive after 5 months of 
treatment. This is also a patient who was initially smear negative and becomes 
smear positive at the end of the first two months treatment 
 Treatment after default: A patient who returns to treatment following 
interruption of treatment for 2 or more consecutive months, with smear or 
culture positive TB (sometimes smear-negative but still with active TB as 
judged on clinical and radiological assessment) 
 Chronic case: A patient who is sputum-positive at the end of a fully supervised 
re-treatment regimen. 
 
For clear analysis of data, end of treatment outcomes are classified as follows (2): 
- Cured patient: patient was initially sputum AAFB positive, but is smear 
negative in the last month of treatment and on at least one previous occasion  
- Treatment completed: treatment has been completed, but patient does not meet 
the criteria to be classified cured or failure. 
- Treatment success: the sum of cured patients and those that have completed 
treatment. 
- Death: patients who die for any reason during the course of TB treatment. 
- Failure of treatment: patient who is sputum smear-positive at 5 months or later 
during treatment. Also patient who was smear-negative before initiating 
treatment but turned smear-positive after the initial phase 
- Treatment interruption: patient who misses treatment. Those who miss 
treatment for 2 consecutive months or more are considered defaulters. 
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- Treatment outcomes for MDR-TB use different criteria that are not specified 
here. 
Table 1: Recommended Treatment Regimens in Botswana (2) 
 
TB 
Diagnostic 
Category 
TB Patients TB Treatment Regimens 
Initial Phase 
(daily)
 
Continuation 
Phase (daily) 
I All new adult cases of TB regardless of 
site, bacteriology or severity of disease, 
and severe TB in children 
2HRZE
 
4HR 
II Previously treated cases of  TB: 
- Retreatment after relapse 
- Retreatment after default 
-Retreatment after treatment failure 
2HRZE 
/1HRZE 
5HRE 
III Less severe cases of TB in children 2HRZ 6HE 
IV Chronic and MDR-TB cases (still 
sputum-positive after supervised re-
treatment)
 
Specially-designed standardized or 
individualized regimens are 
recommended 
Legend: H: Isoniazid, R: Rifampicin, Z: Pyrazinamide, E: Ethambutol, S: 
Streptomycin. 
The number in front of the regimens determines the duration of the course of TB 
treatment in months 
 
C- Community TB Programme   
 
Though accessibility to health facilities is good in Botswana, the burden of the TB 
epidemic is beginning to overstretch human resources. (2, 3) Other approaches need 
to complement the DOTS strategy in order to yield good result in the management of 
TB. (3) Many suggest the use of community members to help in one or another area 
of the TB programme. (3, 6,24) 
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In Africa there is a tradition of communities, and especially women, taking care of 
family members. (3)  The WHO, through its Stop TB strategy, recognizes community 
participation as one of the principles of the Primary Health Care approach. (3,24) 
 
Already communities are successfully supporting the health care system in 
community home based care (CHBC) and support groups for people living with 
HIV/AIDS.(3)  
 
In the case of TB possible community contributions may be (3, 18): 
- supporting patients throughout the entire treatment (general support or DOT) 
- patient, family and community education on TB (to help reduce stigmatization) 
- case finding and case detection (allow screening of TB contacts, submit sputum 
for examination and collect results) 
- recognition of adverse effects leading to defaults 
 
Countries that have well functioning National TB programmes can also benefit from 
community based approaches as this may help them maintain their standards in the 
face of growing deficiencies in human resources. (6) Community involvement in 
dispensing anti-tuberculosis treatment has been tried in urban African (6, 9, 14, 17) 
and Asian (7, 16, 19) settings as well as rural areas. (10, 11)   
 
Furthermore studies have used different community members to help administer TB 
treatment such as family members (8, 15, 19), volunteers (10, 11, 17), previous TB 
patients or established community home based care programme (9) with encouraging 
results. 
 
Community TB care seems also to be well accepted by patients as it helps improve the 
TB knowledge of patients and the community at large and therefore reduces 
stigmatization. (5, 11, 18) 
 
Finally community TB care helps to improve the affordability and cost effectiveness 
of the TB treatment (12), though there remains an issue of incentives for volunteers to 
help sustain the programme. (3, 13) 
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III- PROJECT AIMS AND OBJECTIVES 
 
A- AIM OF THE STUDY 
 
The aim of this study is to assess the success of home-based DOT in the management 
of tuberculosis compared to facility-based DOT in Kweneng West sub-district, 
Botswana and to explore the acceptability of home-based DOT among TB patients, 
TB treatment supervisors and health workers. 
 
B- OBJECTIVES OF THE STUDY 
 
1- To compare treatment outcomes for patients receiving home-based DOT and those 
receiving facility-based DOT through the following criteria: 
    -   Cure rate 
    -   Treatment completion rate 
    -   Treatment success rate 
    -   Mortality 
    -   Treatment failure rate 
    -   Treatment interruption rate 
 
2- To compare patients contact(s) tracing efforts among home-based providers and 
facility-based providers 
 
3- To establish TB patient’s, TB treatment supervisor’s and health worker’s 
perceptions about home-based DOT 
 
IV- STUDY DESIGN AND METHODOLOGY 
 
A- Study setting 
 
Botswana is currently scaling up a community based TB programme. This programme 
aims to allow dispensing of medication to TB patients at their respective homes 
(Home-based DOT). It equates to the usual daily supervision of TB treatment at 
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health facilities (Facility-based DOT). Home-based DOT is made possible by the use 
of community volunteers. After consultation with community representatives in their 
respective catchment areas, health facilities select local volunteers. All volunteers are 
trained in TB treatment supervision. At the onset of TB treatment, patients are 
introduced to both concepts (home-based and facility-based DOT) and are expected to 
choose which mode they prefer. (3) Community volunteers (supervisors) are allocated 
duties according to their readiness and patients and supervisors location.  
 
Community volunteers dispense TB medication in the community for a given number 
of patients. Community volunteers are supervised in their respective catchment area 
by clinic nurses. They are given weekly TB medication for their patients and they are 
expected to report back their activities to the clinic nurses once per week. (3)  
 
Generally nurses have the responsibility of managing records, supervising medication 
intake and guiding the community volunteers. (2) They are supported by health 
education assistants (HEA). HEA are community members that have received a short 
training to allow them to support the link between health facilities and communities. 
(2) They are particularly involved in child welfare clinic and the TB programme. 
They help health facilities to trace defaulters and they record all non-institutional 
deaths that occur in their respective communities. (2) 
 
Medical doctors initiate TB treatment and offer monthly follow up of all TB patients. 
(2) 
 
TB programme data are captured on two tools at health facilities (the health facility 
TB register and individual TB patient cards: see annexes 1 and 2) and two tools at 
district level (the manual TB register and electronic TB register: ETR). (2) District 
records include data from all health facilities in the specific district. (2) 
 
Research will be conducted in Kweneng West Subdistrict, which is a rural area with 
approximately 40000 inhabitants. Kweneng West Subdistrict comprises 23 health 
facilities with 8 main clinics run by the Local Government. It also has a primary 
hospital run by the Boswana Defense Forces (BDF). All health facilities offer TB 
treatment. 
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B- Methodology for objectives 1, 2 
 
Study design: To achieve these objectives the study utilised an observational, 
retrospective study design. Data was collected from routinely pre-filled TB registers 
and individual patient TB cards and three groups of patients were identified according 
to their choice of home-based DOT or facility-based DOT or a mix of the two. 
Comparison of treatment outcomes was made between these arms to assess the 
effectiveness of the home-based DOT relative to the usual facility-based approach.  
 
The choice of this kind of study design stems from its advantages: less expensive and 
less time consuming, it helps demonstrate effectiveness and usually enrols a large 
sample that carries a greater chance to show statistical significance. This is despite its 
disadvantages that include reliance on an accurately maintained database and no 
randomisation of individuals. Lack of randomisation may lead to bias, especially the 
inability to assess all potential confounding factors that may provide alternative 
explanations for differences in outcomes between the groups. Owing to these 
disadvantages, efforts was made to measure as many known confounding factors as 
possible and account for them during analysis (see below). 
 
Study population: TB patients registered in the main clinics of Kweneng West 
Subditrict from June 2006 to June 2008 were considered for this study. Exclusion 
criteria included: MDR/XDR TB cases and patients who were transferred in/out 
whilst on TB treatment. Using a 5 % precision with 95 % confidence interval, the 
sample size required was estimated to be at least 381 respondents. 
 
Study procedures: After a short training on data capturing and issues of ethics, 
research assistants collected and captured data manually on pre-made forms (see 
annex 3). Forms were then sent to the main researcher to enter them in an electronic 
database (data sheet in MSExcel) to allow easy data analysis. Research assistants were 
community TB volunteers as they were already acquainted with the TB programme 
and issues of ethics. A small financial incentive was offered to them for their 
assistance. 
Variables captured from the TB registers at the clinic level were: 
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- Outcome of TB treatment 
- Type of DOT provided (facility-based, home-based, mixed, undetermined) 
- Age 
- Sex 
- HIV status 
- HAART (Highly active anti-retroviral therapy) 
- Type of TB (new/re-treatment, pulmonary/extra-pulmonary) 
However some confounding factors that may be considered interesting (and of great 
importance), may be difficult to measure as the present TB registers in Botswana do 
not capture data about them. For example the general clinical condition of patients 
(bedridden/weak/still able to walk), WHO HIV clinical staging or CD4 count. 
 
Pilot study: After training, research assistants were given an opportunity to capture 
data for 5 patients in the presence of the main researcher who gave them feedback and 
clarified any problems. The main researcher also ran the data sheet in MSExcel using 
any imaginary data to assess its efficiency. 
 
Analysis: Data was collated in Excel and submitted for analysis to the Centre for 
Statistical Consultation (University of Stellenbosch). The analysis looked for any 
association between the type of DOT and TB outcomes while accounting for any 
other measured confounding factors. 
   
C- Methodology for objective 3 
 
Study design: A qualitative study was utilised to complement the results obtained 
during the quantitative study for the 2 previous objectives. This type of study is more 
suitable to assess the beliefs and attitudes of individuals towards a subject. The 
qualitative study was conducted by in-depth interviewing of TB patients, TB 
treatment supervisors (community volunteers) and health workers (nurses and health 
education assistants) who are involved in the home-based DOT and facility-based 
DOT programme. 
 
Study population: Study participants were chosen purposefully in the same areas 
where data was collected for objectives 1 and 2. Study participants were people who 
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are actively involved in the TB programme at the time of research. Study participants 
were chosen as followed: 
- 5 TB patients under home-based DOT 
- 5 TB patients under facility-based DOT 
- 5 TB treatment supervisors  
- 5 health workers (3 nurses and 2 health education assistants).  
Selection of TB patients included all age-groups, both genders and if possible both 
unemployed and working individuals. 
 
Piloting: Main researcher who conducted all interviews had to perform few pilot 
interviews to ascertain the ability of community volunteers to translate. In addition, 
research assistants were trained in the communication skills required for an in-depth 
interview and their role during interviews. 
 
Data collection: The focus of interviews and topics were based on previous research 
findings (5) and other topics have been added considering the particularity of the 
study setting. The in-depth interviews focused differently for each type of 
interviewee: 
 
For TB patients under home-based DOT and facility-based DOT, the interview was 
introduced by the following question:  
“Can you please describe your experience of TB treatment (the type of DOT you 
chose) and how you now feel about receiving the TB treatment in this way?” The 
interview then covered the following topics: 
  - Advantages and disadvantages of the DOT style 
  - Initial reasons for choosing home or facility DOT and reflection now 
  - Experience of volunteer: relationship and attitude 
  - Access to medication and convenience of taking medication 
  - How easy is (was) it to keep to the TB treatment (adherence)? 
  - What made taking the TB treatment easier or harder? 
  - The impact on recovery from TB and the quality of life 
  - What would have made your experience better? 
  - Did you experience any discrimination or stigmatization?   
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For TB treatment supervisors, the opening question was: “Can you please describe 
your experience of supervising medication for a TB patient?” The interview then 
covered the following topics: 
   - How difficult or easy is it to supervise people on TB treatment? 
   - What type of patient benefits from home-based DOT 
   - What challenges do you face in supervising TB treatment? 
   - What suggestions would you make to improve the home-based DOT programme? 
   - What is your experience of working with the staff at the health facility? 
   - What reaction do you get from the broader community towards your work? 
                     
For health workers, the opening question was: “Can you describe the impact of home-
based DOT on the TB treatment programme in your facility?” The interview then 
covered the following topics: 
    - How does home-based DOT help or hinder health workers to manage TB? 
    - How easy or difficult is it to supervise volunteers? 
    - What are the advantages and disadvantages of home-based DOT and facility-
based  
       DOT? 
     - What type of patient should receive home-based DOT? 
     - How sustainable is the home-based DOT programme? 
     - What suggestions would you make to improve the home-based DOT programme? 
 
Main researcher was fluent in English and research assistants were fluent in English 
and Seswana. Either language was used during interviews according to the choice of 
each person. Interviews were recorded on tapes.  
Analysis: The tapes were listened to by the main research and a research assistant for 
interpretation. Transcripts of the translated tapes were prepared in English. Qualitative 
data analysis using the framework approach was then performed by the main 
researcher. 
- Familiarisation: Immersing oneself in the data by reading the transcripts and 
listening to the tapes 
- Creating athematic index: During the familiarisation process the key themes 
and sub-themes that emerge from the data were collated and re-organised into 
an index of themes and sub-themes 
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- Indexing: The transcripts were then re-read and coded throughout using the 
index created above 
- Charting: Data from the transcripts which has received the same index code 
were collated together in a chart so that all qualitative materials on the same or 
similar themes can be juxtaposed 
- Mapping and interpretation: New concepts and theories emerging from the 
analysis were defined, potential associations between themes explored, range 
and strengths of different opinions mapped and the meaning of the findings 
discussed.  
  
V- ETHICAL CONSIDERATION 
 
1- Retrospective study using database 
Debates about obtaining informed consent from all patients whose records were used 
remain philosophical. Practically it is impossible to meet all the patients and such a 
move may perversely erode confidentiality by encouraging the correlation of 
individuals and their respective data. As only routinely collected data were to be used 
in the analysis and without any patient identifiers it was not proposed to obtain 
consent from each patient. Permission was obtained from the district health services to 
collect and analyse the data. The data collectors were trained to respect confidentiality 
of patients when they collected the data from the TB register or personal health 
records. Data were captured first of all on a pre-made form, using only reference 
numbers as codes. A master list of folder numbers corresponding to these codes was 
kept separately by the main researcher. No patient identifiers were used in the analysis 
or reporting. Access to the data files was only allowed by the use of a password 
known to the main researcher. 
2- Interviews: 
Written, informed consents (see annex 4) were obtained from all study participants 
before undergoing the in-depth interview. Interviewers (main and assistants) were 
encouraged to uphold confidentiality as they were privy to patients’ feelings about 
community TB programme. 
Interviews were recorded on tapes and no name was linked to data on tapes. 
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Interviewers started every interview by only introducing the participant reference 
number. A paper-based database captured demographic information under every 
corresponding reference number. This database included elements such as: type of 
respondent (TB patient under home-based DOT, TB patient under facility-based 
DOT, TB treatment supervisor or health worker), sex and age. Consent forms were 
produced in both English and Seswana. 
 
Ethical approval was received from the University of Stellenbosch Committee on 
Human Research, as well as from the Ministry of Health and the Ministry of Local 
Government of the Government of Botswana. 
 
VI- STUDY RESULTS 
 
A- QUANTITATIVE STUDY RESULTS 
 
The study included 405 TB patients whose characteristics are shown in Table II and 
age distribution in Figure 2. 
 
 
Table II: Study participants’ characteristics in different DOT types 
 
 
Variables 
All 
N=405 
FB DOT 
    N=279 
HB DOT 
     N=95 
MX DOT 
    N=31 
P value 
Mean age (years) 36.5 36.5 35.3 40.3 0.52 
Gender 
 
Male n (%) 220 (54) 160 (57) 46 (48) 14 (45) 0.18 
Female n (%) 185 (46) 119 (43) 49 (52) 17 (55) 
 
HIV status 
 
Positive n (%) 191 (47) 131 (47) 43 (45) 17 (55)  
0.13 Negative n (%) 171 (42) 124 (44) 35 (37) 12 (39) 
Unknown n (%) 43 (11) 24 (9) 17 (18) 2 (6) 
 
On HAART* 
 
Yes n (%) 75 (39) 48 (37) 19 (44) 8 (47)  
0.26 No n (%) 68 (36) 52 (40) 11 (26) 5 (29) 
Unknown n (%) 48 (25) 31 (23) 13 (30) 4 (24) 
Location of TB Pulmonary n (%) 322 (80) 216 (77) 82 (86) 24 (77) 0.15 
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Extra pulmonary n 
(%) 
83 (20) 63 (23) 13 (14) 7 (23) 
 
Initial AAFB** 
 
Positive n (%) 121 (38) 92 (43) 24 (29) 5 (21)  
0.14 Negative n (%) 94 (29) 63 (29) 21 (26) 10 (42) 
Not done n (%) 107 (33) 61 (28) 37 (45) 9 (37) 
ATT category New n (%) 350 (86) 214 (86) 95 (100) 14 (45) <0.01 
Retreatment n (%) 55 (14) 38 (14) 0 (0) 17 (55) 
* n = Only patients who are HIV positive 
** n = Only patients with pulmonary TB 
ATT = Anti-Tuberculosis Treatment 
 
 
Figure 2: Age distribution 
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Subsequent to HIV testing, TB patients who are HIV positive are eligible to start 
HAART regardless of their CD4 counts. However the initiation of HAART is 
determined by clinicians who consider the patient’s general condition and their level 
of immuno-suppression. Generally, the onset of HAART is delayed and concomitant 
initiation of HAART and TB treatment is avoided. If the general condition of a patient 
is poor, clinicians may need to introduce HAART as early as 2 weeks after the 
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initiation of TB treatment. Otherwise HAART initiation may wait until the end of the 
intensive phase or the completion of TB treatment. 
 
The Botswana National TB programme encourages health workers to perform smear 
testing for the presence of AAFBs in case of pulmonary TB. In so doing clinicians 
would avoid excessive reliance on chest radiography for TB diagnosis. In this study, 
there were 322 patients with pulmonary TB, among whom 215 (66.8%) had an initial 
AAFB result at the onset of TB treatment. 
 
Table II also compares the study participants’ characteristics in terms of the different 
types of DOT that they experienced. In Botswana, TB patients are free to choose 
between facility-based DOT and home-based DOT. In particular situations, some 
patients may start TB treatment under FB-DOT and end up in HB-DOT or vice versa; 
hence a third mixed group (MX-DOT) has been considered in this study. The late 
introduction of HB-DOT in some areas of the sub-district may have contributed to the 
uneven enrolment among the different DOT. Indeed some areas started HB-DOT only 
in early 2008. 
 
The groups receiving different DOT types did not differ statistically in any of the 
characteristics except the category of TB treatment. None of the re-treatment patients 
(n=55) was considered for exclusive home-based DOT and 38 (69%) received 
exclusive facility-based DOT, while 17 (31%) were mixed. The main reason for this 
difference is the need for re-treatment patients to receive streptomycin injections 
during the intensive phase of treatment. 
 
Table III compares the outcome of TB treatment between the three types of DOT and 
the efforts to trace TB contacts. Overall the successful treatment rate (sum of cured 
and completed cases) was 83%. 
 
 
 
 
Table III: Comparison of overall outcome of TB treatment and contact tracing efforts 
among the different DOT types 
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Variables All 
N=405 
N (%) 
FB DOT 
N=279 
N (%) 
HB DOT 
N=95 
N (%) 
MX DOT 
N=31 
N (%) 
P 
value 
 
Treatment 
Outcome 
 
 
Cure 95 (23) 71 (25) 19 (20) 5 (16)  
 
0.45 
Complete 244 (60) 164 (59) 58 (61) 22 (71) 
Died 52 (13) 34 (12) 15 (16) 3 (10) 
Interrupted 9 (2) 8 (3) 1 (1) 0 (0) 
Failure 5 (1) 2 (1) 2 (2) 1 (3) 
Contact 
tracing 
Yes 245 (60.5) 190 (68) 48 (50.5) 7 (22.5) <0.01 
No 160 (39.5) 89 (32) 47 (49.5) 24 (77.5) 
 
The outcome of treatment did not differ significantly between any of the three groups. 
However health workers in FB-DOT group faired better in efforts to trace contacts of 
TB patients. Community volunteers in HB-DOT did contact tracing in fewer TB 
patients, and the MX-DOT group was worst in its attempts to trace contacts of TB 
patients. 
 
Table IV shows the cure rate in terms of the total number of patients who had an 
initial positive AAFB (smear positive pulmonary TB patients) as opposed to all 
registered patients. Again there was no significant difference between the DOT types 
Table IV: Comparison of cure rates for smear positive pulmonary TB patients among 
different DOT types 
 
 All 
N= 121 
FBDOT 
N= 92 
HBDOT 
N= 24 
MXDOT 
N= 5 
P value 
Number of 
cured 
patients 
(cure rate)  
 
95 (78.5%) 
 
71 (77.2%) 
 
19 (79.2%) 
 
  5 (100%) 
 
      0.48 
 
 
B- QUALITATIVE INTERVIEW RESULTS 
 
Advantages of facility based DOT 
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Some patients believed that the stricter environment of the clinic was more likely to 
ensure their ongoing adherence to TB treatment: 
 
“Because I feared getting tired of taking tablets and therefore become tempted to hide 
them or throw them instead of taking them. At clinics I took them in the presence of 
the health care worker” Patient 
 
“It is just too serious at clinics as one takes tablets in front of the nurses” Patient 
 
While others felt more secure knowing that more highly trained staff were 
theoretically more available to them: 
 
“I feel safe when I know the doctor is nearby and can intervene anytime if something 
goes wrong” Patient 
 
Health care workers also felt that problems were more likely to be detected early in 
FB-DOT:  
“On-going counselling, direct supervision by highly trained health workers, daily 
assessment of patients and therefore early detection of toxicity and side effects signs 
are of great importance” Health worker 
 
Disadvantages of facility based DOT 
 
Patients and community volunteers recognised that the disadvantages of facility based 
DOT included longer travel time and distances and longer waiting times for treatment 
at the clinic. The effort and time needed therefore to obtain treatment at clinics might 
adversely affect adherence: 
 
“Weekly or fortnightly supply may help their experience be better. Having extra 
manpower over weekends at clinics may reduce the nightmare faced by a single nurse 
and all patients” Patient 
 
“Patients may choose to stay home and not go late to far away health facilities” 
Volunteer 
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“Waking up early in the morning to queue at the clinics is difficult and 
inconveniencing, we don’t get enough rest” 
 
Advantages of home based DOT 
 
Obtaining treatment from a community volunteer was less stressful as it required less 
effort and a convenient more flexible time could be negotiated. 
 
“[HBDOT] allows us to rest enough and does not stress us as we would have usually 
agreed with volunteers about a specific time to meet.” Patient  
 
Home based DOT was also an advantage for those too sick to travel every day to the 
facility and for those who struggled to eat before taking medication at the clinics. Not 
being able to eat might lead to more side effects and reduced adherence. 
  
“Community TB programme has come on time to help us. At times we are too sick to 
walk to the clinics everyday. Clinics advise us to eat before medication intake but by 
the time we take tablets at clinics, the food would have dissolved in the stomach. At 
home the volunteer deals with few people and gives time to patients to eat some 
porridge in the morning before medication” Patient    
 
“[The feeling] we have of helping sick people in our own community, people who are 
very weak or who stay far from health facilities” Volunteer 
 
“We are helping sick people in our own community, people who are very weak or who 
stay far from health facilities” Volunteer 
 
Home based DOT allows patients to engage more fully in other aspects of their lives: 
 
“HB DOT is well designed to help workers or non-workers to take tablets at an 
agreed time with their community supervisors. Patients may then have time to take 
care of other businesses instead of staying at clinics the entire day.”  
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Nurses also saw these advantages and in addition perceived that their workload was 
reduced and the need for them to do home visits. They also recognised that attending 
the facility might place an additional financial burden on the patient.  
 
“Of course HBDOT reduces the travelling distance to clinics for patients, it reduces 
workload for nurses, it reduces the daily transport cost of very ill patients to/fro 
clinics for medication or the need for home visits by nurses and the disturbance of 
visiting patients at home when they are still asleep” Nurse 
 
Home based DOT is also an advantage on weekends when clinics may be closed: 
 
“HBDOT is of incredible help during weekends when health posts close” Nurse 
 
“HB DOT is helpful during weekends when health posts are closed.” Patient  
 
 
Disadvantages of home based DOT 
 
Patients had fears about taking TB treatment under HB-DOT that could affect their 
adherence to medication. 
 
“We are however sometimes worried about our own safety as volunteers are 
perceived to be not fully knowledgeable about doses and side effects of medication for 
instance”. Patient 
 
 “I feel it is safe to take treatment at clinics, though I feel tired some days or I have 
painful legs. The health workers have been taught details about how to give these 
tablets.” Patient     
   
Health care workers concurred with these fears and the possibility that volunteers 
were not sufficiently knowledgeable:  
 
“Patients may also have little trust in volunteers”. Health worker 
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“HBDOT unfortunately involves volunteers that are not perfect about TB management 
and may still have problems with some aspects of TB management. There are also 
concerns about the change of time of medication intake”. Health worker 
 
It is therefore understandable why volunteers suggested to health workers to pay 
regular visits to communities where they (health workers) could continue health 
education and re-enforce what volunteers had taught: 
 
“Nurses need not abandon us with the patients during the entire course of treatment. 
They (nurses) need to meet TB patients and communities regularly to re-enforce our 
education. It may even increase confidence of patients in us as nurses would confirm 
what we usually say”. Volunteers  
 
Health workers also worried that community volunteers may not always supervise 
strictly in the long term: 
 “Patients may relax and volunteers may be lenient to members of their community”. 
Health worker    
 
A further problem is that there is sometimes no substitute when community volunteers 
are not available:  
 
“No back up plan when volunteers have funerals or are ill”. 
 
Organisational issues  
 
Interviews with patients on FB DOT frequently revealed that they had incomplete 
knowledge about the existence of HB DOT. Sometimes they didn’t know they were 
free to choose to take tablets from home or from health facilities. Below is a 
conversation with some patients: 
 
Interviewer: “Did you know that at home you would take TB tablets in the presence of 
the community volunteers”? 
Patient 1: “Is it? I didn’t know. I thought I would just get a supply for few days and 
then swallow them at my own time” 
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Problem patients on HB DOT may be referred back to the facility when supervision is 
difficult: 
 
“It is discouraging to look after patients who refuse to take medicines (hide them or 
throw them) or patients who still take alcohol. Fortunately, stubborn patients may be 
referred back to health facilities for follow up” Volunteer 
 
In addition to visiting patients at home, volunteers may also supervise patients in their 
own home, which makes supervision more time efficient for them: 
 
“Patients walking to our places (volunteer’s house) for medication has made 
supervision very easy and gives us time to finish this work and deal with our personal 
activities”. 
 
Though not specifically allowed by the national TB programme, the provision of such 
flexibility that allows combination of facility, home and even school based 
supervision can support adherence and quality of life: 
 
 “I felt that taking TB tablets was disturbing my school attendance, hence I allowed 
my teacher to keep my tablets and issue them to me daily. During weekends I instead 
take medication from the clinic. I think this arrangement is advantageous to me” 
School boy on TB treatment 
 
The need for greater flexibility was still an issue for some patients: 
 
“How can I go to plough the field some 25km away from here if everyday I have to 
take the TB tablets in the presence of a supervisor? What am I going to eat this year? 
Why don’t they allow farmers to go back to their work when they feel a bit better?” 
 
Although relying on unpaid volunteers renders HB DOT cost effective, its long term 
sustainability seems threatened: 
 
“HB DOT requires only few resources”.  
 28 
 
“HBDOT won’t be sustainable as there is high turnover of volunteers due to no 
incentive. National TB programme should tackle this issue urgently” 
 
Despite this issue, community volunteers perceive the community TB programme to 
be acceptable to patients: 
 
“It may go a long way if few problems are managed as communities have generally 
accepted us and take us like nurses”.  
 
They appreciate the privileged position that their role in HB DOT allows them to 
attain in the community, but they need some form of identification. Indeed 
identification and other clothing / equipment will ease their movement and encourage 
them:  
 
“Do you know that sometimes even clinic staff fails to identify us. We need uniform 
and some form of sticker to write our names on to help people identify us” 
  
“People take us as nurses and that inspires respect, why then not have 
identification?” 
  
“We need umbrellas and other protective cloths/boots to wear when it is raining, cold 
or very hot”.  
 
Health workers think that the National TB programme has to take some bold decisions 
before HB DOT collapses. Among their recommendations for improvement, one can 
note the need for:       
- financial incentives for volunteers 
- training of additional volunteers to help cover more areas 
- organisation of regular refresher workshops for volunteers to assist them to maintain 
their standards and acquire more knowledge 
- the district TB coordinator, local government and ministry of health officials to pay 
regular supportive visits to volunteers (not only clinic staff). It may encourage them 
and make them feel appreciated 
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- constant availability of data capturing/monitoring tools (forms) 
- reliable transportation to allow daily home visits of TB patients by health workers.  
 
VII- DISCUSSION 
 
A- Main findings of the study 
 
No difference in TB treatment outcomes was found between facility-based, home-
based and mixed types of offering DOT. It would appear therefore that home-based 
DOT is as good as facility-based treatment. The choice of DOT may be flexible based 
on the need for injections, patient preference and availability of different DOT 
options. It is likely that providing greater choice and matching the treatment plan 
more closely with patient preferences will lead to greater satisfaction and adherence to 
treatment. Indeed despite many disadvantages raised about HB-DOT, outcome of 
ATT remained comparable to the one in FB DOT; this shows at least the commitment 
of patients to their choice of DOT. 
 
Also, daily administration of ATT under supervision seems to bother some TB 
patients. In some of these patients, mixing different DOT types appears to be 
necessary to allow patients the flexibility they need for other priorities. This is why a 
school boy enjoyed mixing HB DOT and FB DOT to avoid missing classes; and 
farmers, particularly, find it difficult to stay next to clinics for the entire course of 
ATT. For the latter category of patients, the much needed flexibility of DOT may still 
be elusive. Many other patients also mixed FB-DOT and HB-DOT, either 
concomitantly or consecutively. Some patients under MX DOT are those who started 
ATT under FBDOT and found it more flexible to move to HBDOT once they became 
clinically stable and could return to work. Other patients under MX DOT are those on 
re-treatment regimen who needed streptomycin during the initial phase of TB 
treatment. Community volunteers are not allowed to inject patients but they would 
give oral medication to patients whilst nurses would inject them. The latter situation 
was observed in a few instances where nurses went against the national TB 
programme inclusion criteria into HB-DOT by enrolling re-treatment TB patients to 
HB-DOT. These apparent innovations saved several desperate situations and need to 
be formalised with clear distribution of roles among the different caregivers as indeed 
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almost 8 % (35 out of 405) of all study participants found themselves in MX-DOT. In 
support of formalisation of MX DOT is its outcome of ATT performance that 
remained non-statistically significantly different to FB-DOT and HB-DOT.  
 
Overall cure rate was 78.5%, which is below the WHO target as well as the Botswana 
National TB programme target of 85%. 
The successful treatment rate was 83%, which is close to the WHO target of 85% and 
above the Botswana National TB programme target of 75%. 
 
Facility-based health workers were found to be more proactive in contact tracing than 
the home-based volunteers. Given the volunteers’ greater engagement and 
involvement in the community, this was an unexpected finding. Is this poor 
performance a reflection of the lack of trust in the relationship between patients and 
community volunteers or a lack of knowledge of community volunteers about some 
aspects of TB management? This situation requires further analysis but in case of the 
latter option the national TB programme would need to revise the curriculum offered 
to community volunteers during their training and include discussions emphasising 
the importance of contact tracing. Such curriculum would move the responsibility of 
community volunteers beyond dispensing only to include activities related to early 
detection of TB, specifically contact tracing. Considering their performance in other 
aspects of treatment outcome, it is more plausible that community volunteers may 
perform well concerning contact tracing if they are educated about it and are 
diligently allowed to be involved. Patients with MXDOT did even worse in contact 
tracing as probably no single caretaker took the responsibility of screening close 
contacts to TB patients. 
 
B- Relation of findings to literature 
 
The findings of this study concur with those obtained for community based DOT from 
more ideal situations offered in clinical trials (6,14) . Also its results join those 
concerning treatment outcome from several other observational studies conducted in 
different settings (7,10, 20), making its implementation a likely complementary 
intervention to support the traditional FB-DOT.  
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On the other hand this study did not demonstrate that outcomes from HB-DOT can be 
better than FB-DOT (9,11). Many other studies did so. A study in Zambia (9) was 
conducted in an urban area at a time when HIV had emerged and many TB patients 
were interrupting ATT due to weakness and inability to walk to health facilities. This 
study was also in an environment where ATT was offered for 8 months to new 
patients and strict DOT implemented only during the initial phase. In its HB DOT 
initiative, this TB programme allowed community volunteers to provide DOT at 
home. HB DOT showed a better completion rate, and later, when volunteers became 
more involved in collection of follow up sputum, even cure rates became better. 
However it is not clear if TB patients under HB DOT received any HAART. Also, 
another study in Uganda (11) was conducted in rural area and compared two periods, 
one without HB DOT and the other one with HB DOT option. At the difference with 
Botswana, DOT was traditionally offered during the first two months of ATT and no 
DOT afterwards. During the period of introduction of HB DOT, patients would be 
admitted for two weeks initially and would carry on with HB DOT until the end of 
treatment. The introduction of HB DOT had a tremendous positive impact as it 
avoided defaulting ATT.  
 
An attempt to assess the use of family members as treatment supervisors in 
industrialised countries showed worse adherence to ATT in the HB-DOT group. In 
this study, TB patients were randomly allocated to FB DOT or HB DOT. TB patients 
under HB DOT freely chose a family member to supervise them. Analysis was carried 
per intention-to-treat and saw many picked family members not committed. Also, 
where they accepted to help supervision, they were swayed by emotions and therefore 
not reliable for compliance (8). But same type of study conducted in a developing 
country yielded results that showed better adherence to ATT in patients under HB-
DOT (15). The latter results and present study results demonstrate the reliability to 
HB DOT, at least in developing countries.   
 
Finally, a qualitative study conducted as focus group discussions in Tanzania (5) 
showed similar perceptions to present study about HB DOT among TB patients, 
community volunteers and health workers; though this study was using previous TB 
patients as treatment supervisors. Among reasons cited by this study to support the 
introduction of HB DOT, relief of overcrowding in clinics and cost effectiveness and 
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easy time management came up clearly. Also volunteers requested to be regularly 
visited by health workers. And the different stakeholders expressed concerns about 
the sustainability of HB DOT as community volunteers may need to find other jobs or 
activities to financially support their respective families. Another qualitative study in 
Uganda (11) using an assessment of knowledge, attitudes and beliefs also supports the 
link between patients’ own choice of DOT type and their commitment to complete 
ATT. It also shows that many TB patients had chosen HB DOT due to its cost 
effectiveness (patients travel short distance) and its flexibility as patients and 
community volunteers agree on what time to meet. 
       
C- Strengths and weaknesses of study 
 
A particular strength is the combination of quantitative, analytical methods with 
exploratory qualitative interviews, which captured a more complete picture of the 
process as well as the outcome of care. This study also reports results from the actual 
health care setting rather than from the more ideal conditions created by a randomised 
clinical trial. During the period considered for the present study, the Subdistrict TB 
programme registered 706 TB patients. Considering the exclusion criteria, 405 TB 
patients were recruited as study participants. However the MX-DOT as a special 
arrangement was not expected and was allowed by the TB programme only for few 
patients whose analysis was therefore affected by its small sample size. 
 
Another weakness is the potential effect of measured and unmeasured confounding 
factors on outcomes between the different groups. In this study only confounding 
factors registered in the TB registers were considered. Other confounding factors that 
may have been relevant were not available such as CD4 count, WHO HIV clinical 
staging and other co-morbidities.   
 
In terms of interviews, it is important to recall their subjectivity and the potential for 
mis-interpretation of meaning through the process of translation and analysis. 
However main researcher conducted all interviews, accompanied by assistants that are 
fluent in the local language.  
 
D- Need for future research and recommendations for the health system 
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Future studies that may assist with the further evaluation of HB DOT are: 
- Investigation of the surprising difference in contact tracing efforts 
- Investigation of programmes that may give more flexibility and choice to 
patients 
- Re-evaluation of the community TB programme following the implementation of 
recommendations given in this study. 
 
Present study results will be shared with local managers, health workers and 
communities to highlight the equal performance of the different DOT types in terms 
of TB management outcomes. There is a need to continue educating patients and 
communities regarding the availability and potential benefits of HB-DOT. And in this 
regard, one may point to the benefits offered by a more flexible DOT tailored to 
patients’ circumstances and preferences.  
 
It is worth noting some factors that explain the choice of the different DOT types as 
obtained from interviews: 
 
Reasons to choose facility based DOT 
 
Reasons to choose home based DOT 
1. Need to obtain injections 
2. Feel more secure being treated by 
a nurse than a volunteer 
3. Live close to a clinic 
4. Not too weak to travel 
 
1. Live very far from clinic  
2. Too weak to travel 
3. Can’t afford to travel to clinic 
4. Easier to eat at home before 
taking treatment 
5. Flexible for workers/students 
 
 
HBDOT may be improved and strengthened by consideration of the following issues: 
 
 Regular talks with TB patients by health care workers to reinforce on-going 
counselling by community volunteers 
 34 
 Continuing professional development and education of volunteers to ensure they 
are competent and up-to-date 
 Education and support for contact tracing by community volunteers 
 Uniform and some form of identification for community volunteers 
 Financial incentives for community volunteers, though challenging needs to be 
considered critically.   
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